PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.44 - 1.45
1.18 - 2.36
61.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
26.04%
Revenue growth under 50% of 1113.HK's 92.18%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
26.47%
Gross profit growth at 75-90% of 1113.HK's 32.59%. Bill Ackman would demand operational improvements to match competitor gains.
16.15%
EBIT growth below 50% of 1113.HK's 35.59%. Michael Burry would suspect deeper competitive or cost structure issues.
24.41%
Positive operating income growth while 1113.HK is negative. John Neff might view this as a competitive edge in operations.
13.43%
Positive net income growth while 1113.HK is negative. John Neff might see a big relative performance advantage.
15.79%
Positive EPS growth while 1113.HK is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
15.79%
Positive diluted EPS growth while 1113.HK is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.75%
Share count expansion well above 1113.HK's 0.00%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.75%
Diluted share change of 0.75% while 1113.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
11.35%
OCF growth under 50% of 1113.HK's 204.28%. Michael Burry might suspect questionable revenue recognition or rising costs.
-12.85%
Negative FCF growth while 1113.HK is at 268.66%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-13.79%
Negative 10Y revenue/share CAGR while 1113.HK stands at 526.54%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
1379.14%
5Y revenue/share CAGR above 1.5x 1113.HK's 389.92%. David Dodd would look for consistent product or market expansions fueling outperformance.
551.89%
3Y revenue/share CAGR above 1.5x 1113.HK's 42.35%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-122.95%
Negative 10Y OCF/share CAGR while 1113.HK stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
56.99%
Below 50% of 1113.HK's 364.59%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
44.35%
3Y OCF/share CAGR similar to 1113.HK's 44.92%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
-206.81%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
77.04%
Positive 5Y CAGR while 1113.HK is negative. John Neff might view this as a strong mid-term relative advantage.
-0.95%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
-36.08%
Negative 5Y equity/share growth while 1113.HK is at 273.75%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-28.34%
Negative 3Y equity/share growth while 1113.HK is at 32.55%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Cut dividends over 10 years while 1113.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
40.22%
We show growth while 1113.HK is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.35%
Asset growth well under 50% of 1113.HK's 6.61%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-8.73%
We have a declining book value while 1113.HK shows 3.26%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
53.68%
Debt growth far above 1113.HK's 35.54%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-0.18%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.